Targeted Therapies in Cancer: To Be or Not to Be, Selective
Development of targeted therapies in recent years revealed several nonchemotherapeutic options for patients. Chief among targeted therapies is small molecule kinase inhibitors targeting key oncogenic signaling proteins. Through competitive and noncompetitive inhibition of these kinases, and therefor...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
MDPI AG
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/cfeba3ffd4da484b9306a09a2d8a6e44 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|